Ileostomy Market Size and Share
Ileostomy Market Analysis by Mordor Intelligence
The ileostomy market stood at USD 1.31 billion in 2025 and is predicted to reach USD 1.86 billion by 2030, advancing at a 7.30% CAGR. The expansion stems from three converging forces: an ageing population with higher inflammatory bowel disease (IBD) incidence, steady colorectal-cancer surgery volumes, and rapid product innovation in two-piece drainable systems. North America remains the largest regional contributor, while Asia-Pacific registers the quickest uptake thanks to hospital-capacity upgrades and growing life expectancy. Procedure patterns are also evolving; surgeons now favour temporary loop ileostomies for bowel preservation, yet permanent end procedures still dominate volumes. Competitive intensity is moderate as leading firms differentiate through digital leakage alerts, mouldable skin barriers, and service-backed care ecosystems.
Key Report Takeaways
- By procedure type, end ileostomy led with 62.54% of ileostomy market share in 2024, whereas loop ileostomy is forecast to post a 7.81% CAGR through 2030.
- By system type, two-piece products captured 58.27% of the ileostomy market in 2024; one-piece solutions are projected to expand at 8.05% CAGR to 2030.
- By equipment, stoma bags accounted for 76.31% of the ileostomy market size in 2024; accessories and others segment is set to grow at 8.12% CAGR during 2025-2030.
- By disease, cancer contributed 42.93% revenue share in 2024, while Crohn’s disease is advancing at 8.95% CAGR to 2030.
- By end user, hospitals held 51.25% share of the ileostomy market size in 2024, and home care is projected to rise at 8.49% CAGR over the forecast period.
- By geography, North America commanded 43.28% share of the ileostomy market in 2024; Asia-Pacific is the fastest-growing region at 8.84% CAGR to 2030.
Global Ileostomy Market Trends and Insights
Drivers Impact Analysis
Driver | (~) % Impact on CAGR Forecast | Geographic Relevance | Impact Timeline |
---|---|---|---|
Rising prevalence of inflammatory bowel disease (IBD) | +1.8% | North America & Europe highest, global spread to Asia & Latin America | Long term (≥ 4 years) |
Growing colorectal-cancer surgical incidence | +1.5% | Global, with accelerating volumes in Asia-Pacific | Medium term (2-4 years) |
Ageing population & chronic disease burden | +1.2% | Core impact in Asia-Pacific, spill-over to North America & Europe | Long term (≥ 4 years) |
Advances in two-piece drainable bags | +0.9% | Early adoption in developed markets, expanding worldwide | Short term (≤ 2 years) |
Emergence of digital stoma-monitoring wearables | +0.6% | North America & EU first, rolling out to Asia-Pacific | Medium term (2-4 years) |
Adoption of 3-D printed custom-fit skin barriers | +0.4% | Pilot programmes in North America & EU | Long term (≥ 4 years) |
Source: Mordor Intelligence
Rising Prevalence of IBD
Age-standardized IBD incidence climbed from 4.22 to 4.45 per 100,000 between 1990 and 2022. Elderly cohorts show the sharpest rise, with women aged 60-89 exhibiting the greatest case growth. Newly industrialised nations in Asia, Africa, and Latin America are entering an acceleration phase, signalling sustained global demand for advanced stoma solutions. As medical therapy fails for complex cases, permanent or temporary ileostomies become essential, boosting premium product uptake that preserves peristomal skin integrity while accommodating multiple comorbidities.
Growing Colorectal-Cancer Surgical Incidence
Colorectal cancer constitutes 38.5% of the lifetime risk for gastrointestinal tumours worldwide [1]Jean-Nicolas Vauthey et al., “Lifetime GI-Cancer Risk Analysis,” thelancet.com. Early-onset cases are advancing fastest, compelling surgeons to perform protective diverting ileostomies in younger, active patients who prioritise discreet appliances. Colon cancer rates among Asian Americans rose from 155 to 755 per 100,000 between 2017 and 2022, underscoring the shift toward high-quality, lifestyle-compatible systems. Demand centres on devices that simplify short-term use and safeguard skin for planned reversals.
Ageing Population & Chronic Disease Burden
Adults aged over 45 face a mounting hernia and bowel-surgery burden that often culminates in ostomy formation [2]BMC Gastroenterology, “Hernia Disease Projection,” bmcgastroenterol.biomedcentral.com. China illustrates the economic scale: per-capita health outlays are expected to climb to USD 30,800 by 2060 under current demography. Older users need easy-to-handle barriers and caregiver-friendly closures, prompting manufacturers to refine ergonomic flanges, colour-coded coupling, and belt-integrated support for limited dexterity.
Advances in Two-Piece Drainable Bags
ConvaTec’s mouldable technology maintained healthy peristomal skin in 95% of users and improved dermatitis scores in 86% of switchers. Surveys reveal over 90% of wearers find mouldable two-piece appliances faster and less stressful than cut-to-fit types. Randomised data show belts raise overall life satisfaction and body image after eight weeks of use. These gains spur premium demand in developed markets and reinforce two-piece leadership within the ileostomy market.
Restraints Impact Analysis
Restraint | (~) % Impact on CAGR Forecast | Geographic Relevance | Impact Timeline |
---|---|---|---|
Shift toward minimally-invasive bowel-sparing procedures | -0.8% | Greatest effect in developed markets | Medium term (2-4 years) |
Cost & reimbursement gaps in developing economies | -0.6% | Asia-Pacific, Middle East & Africa, Latin America | Short term (≤ 2 years) |
Supply-chain vulnerability of hydrocolloid adhesives | -0.4% | Global, regional variability | Short term (≤ 2 years) |
Waste-disposal regulations for single-use ostomy products | -0.3% | EU & North America first, extending globally | Long term (≥ 4 years) |
Source: Mordor Intelligence
Shift Toward Minimally-Invasive Bowel-Sparing Procedures
Robotic colorectal surgeries now report fewer complications and shorter stays versus open approaches. US data show robotic use rising in stoma reversals, indicating surgeon preference for direct anastomosis when technology reduces risk. Professional guidelines confirm laparoscopic and robotic methods lessen pain and length of stay while maintaining oncologic safety. As proficiency spreads, fewer patients require protective ileostomies, tempering demand in advanced health systems.
Cost & Reimbursement Gaps in Developing Economies
Surveys in Malawi, Nigeria, India, and the Philippines document limited access to affordable stoma supplies and counselling. Out-of-pocket purchasing, inconsistent insurance, and sparse rural distribution restrict premium uptake, urging suppliers to launch low-cost lines with simpler adhesives. These constraints widen the quality divide between high-income and price-sensitive segments in the ileostomy market.
Segment Analysis
By Procedure Type – End Procedures Dominate but Loop Demand Accelerates
End ileostomy accounted for 62.54% of 2024 revenue, anchoring the ileostomy market with long-term users whose appliance lifespan can exceed a decade. Post-operative complexity and higher stoma output push hospitals to select durable two-piece barriers with reinforced hydrocolloid bases. The competing loop segment, though smaller, posts a 7.81% CAGR as surgeons increasingly construct temporary diversions for low-anterior resections. Quality-improvement projects prove that timely reversal trims 30-day readmissions from 20.10% to 8.75%. Manufacturers therefore design lightweight, skin-gentle systems that simplify changes during the short active period.
The loop surge expands the ileostomy market by recruiting younger patients who value ease of removal before re-anastomosis. Educational apps guide them through emptying schedules, output tracking, and early warning signs. Combined with nurse-led tele-follow-ups, these tools cut emergency visits and reinforce brand loyalty. Consequently, procedure-specific kits with pre-cut sizing and colour-coded panels are gaining traction among colorectal centres.
Note: Segment shares of all individual segments available upon report purchase
By Equipment Type – Stoma Bags Retain Core Value While Accessories Flourish
Stoma bags represented 76.31% of 2024 revenue, confirming their central role in the ileostomy market. High demand persists for drainable pouches with integrated filter membranes that mitigate ballooning and odour. Yet accessories and others segment races ahead at 8.12% CAGR, propelled by barrier wipes, adjustable belts, and deodorising gels. Clinicians now deploy malodour-reducing additives that lower odour intensity scores and enhance social confidence.
Risk-stratified protocols limit peristomal skin complications to 6.2% by 90 days when advanced barrier rings and convex cushions are combined with structured teaching. This evidence encourages suppliers to bundle pouches with accessory starter packs, embedding long-term usage habits and elevating average selling price. The growing accessory mix further diversifies revenue streams within the ileostomy market.
By Disease Type – Cancer Still Leads as IBD Drives Future Growth
Cancer surgeries captured 42.93% of 2024 sales, anchoring the ileostomy market in oncology wards. Nonetheless, Crohn’s disease delivers the steepest 8.95% CAGR as chronic relapses mandate repeat surgeries and possible permanent diversion. Fecal calprotectin measurement from stoma effluent offers a non-invasive biomarker for flare monitoring. Product designers now integrate sampling ports that allow clinicians to collect effluent without detaching pouches, easing disease surveillance.
Regional epidemiology reinforces the trend. India is projected to witness disproportionate IBD prevalence growth by 2050. Consequently, suppliers are tailoring high-output pouches with extended-wear taps that connect to bedside collectors, addressing unpredictable drainage patterns typical of severe Crohn’s. These disease-specific advances preserve momentum in the ileostomy market
By System Type – Two-Piece Flexibility Versus One-Piece Simplicity
Two-piece systems owned 58.27% of 2024 revenue, reflecting user preference for changing bags without disturbing the skin barrier, an essential feature in high-output scenarios. Improved coupling clicks and tactile feedback reassure visually impaired or elderly wearers. Conversely, the one-piece category logs an 8.05% CAGR as adhesive science and flexible wafers reduce leakage anxiety. Surveys confirm mouldable one-piece products now rival two-piece for wear-time while simplifying morning routines.
Continuous product education underpins better outcomes; an AAH white paper links correct system choice with up to 40% fewer peristomal complications. As differentiation narrows, firms add QR-code videos and multilingual guides to drive proper fitting. Both system types thus sustain parallel growth corridors, expanding the overall ileostomy market size for system innovators.
By Usability – Drainable Bags Prevail yet Closed-End Niches Rise
Drainable options dominated 68.43% of 2024 expenditure, meeting the clinical reality of liquid output. Soft-tap extensions now attach directly to bed-side containers, reducing nocturnal emptying for hospitalised patients and freeing nursing time. Closed-end bags, though smaller, rise at 8.27% CAGR, serving travel, sports, and intimate-activity niches where single-use discretion outweighs cost.
Selective continence devices such as internal plugs yield 67.4% continence and 74.9% quality-of-life gains. Producers therefore invest in hybrid bags that toggle between drainable and closed-end modes, merging convenience with environmental waste reduction goals. This dual-design trend underlines how usability features fuel continuous differentiation within the ileostomy market.

Note: Segment shares of all individual segments available upon report purchase
By End User – Care Shifts from Inpatient to Home
Hospitals held 51.25% revenue share in 2024, but policymakers worldwide now promote same-day colorectal surgery and tele-follow-up, favouring home-based recovery. The home-care channel hence climbs at 8.49% CAGR as families assume daily stoma management. Early rehabilitation programmes help 72% of working-age patients return to employment within six months when supported by interdisciplinary teams.
App-linked reorder reminders and subscription deliveries reduce supply lapses, further entrenching home care growth. Ambulatory surgical centres, with lean cost structures, expand ostomy volume too, especially for elective loop closures. Collectively, shifting sites of service recalibrate demand patterns, stimulating fresh go-to-market models in the ileostomy industry.
Geography Analysis
North America generated 43.28% of 2024 revenue, cementing its leadership through specialist nursing density, widespread insurance coverage, and rapid adoption of digital leakage monitors. FDA alignment with ISO 13485 in 2025 ensures smoother premarket submissions, fostering swift technological upgrades. Despite laparoscopic uptake tempering new stoma creation, premium upselling offsets volume softness, keeping the ileostomy market size resilient.
Asia-Pacific remains the quickest climber with an 8.84% CAGR to 2030. Urban hospitals in China and India now stock convex-fit barriers and adjustable belts, reflecting higher disposable incomes. China’s health-spend trajectory towards USD 33.4 trillion by 2060 reinforces structural demand for chronic-care devices. Emerging reimbursement pilots in Thailand and Indonesia further unlock access, although rural distribution gaps persist.
Europe presents a mature yet innovation-minded landscape. The EU Packaging and Packaging Waste Regulation forces all medical packaging to be recyclable by 2030. Producers have responded with thinner, mono-material pouches that sustain barrier properties while cutting plastic weight. Simultaneously, single-use-device reprocessing rules guide safe recycling of support belts and closure clips. These regulatory nudges drive sustainable product redesign within the ileostomy market.

Competitive Landscape
Coloplast, ConvaTec, and Hollister collectively anchor the competitive field, each backing flagship launches with educational platforms. Coloplast advanced digital sensing through Heylo, offering real-time leakage alerts via smartphones. Hollister reinforced high-output management with integrated soft-tap pouches for critical-care settings.
Mid-tier firms B. Braun and 3M sharpen differentiation on region-specific lines such as Flexima Active for Asian users needing slimmer profiles. The FDA’s predetermined change-control plans enacted in 2024 streamline iterative upgrades, incentivising rapid material tweaks without fresh regulatory dossiers [3]Federal Register, “FDA Quality System Regulation Amendments,” federalregister.gov. Competitive focus has therefore shifted from price to lifetime episode cost, with vendors bundling tele-nurse support, skin-monitoring apps, and replenishment logistics into subscription models.
White-space opportunities persist in paediatric stomas, personalised 3-D printed barriers, and AI-powered wearables predicting effluent pH shifts before leakage. Start-ups collaborating with university additive-manufacturing labs can now prototype customised flanges within 24 hours, trimming fitting appointments and hospital revisits. As digital ecosystems mature, future winners in the ileostomy market will likely marry physical devices with data-driven service layers that guarantee outcome-based contracting to payers.
Ileostomy Industry Leaders
-
ConvaTec Inc.
-
B. Braun Melsungen AG
-
Coloplast
-
Hollister Incorporated
-
Salts Healthcare
- *Disclaimer: Major Players sorted in no particular order

Recent Industry Developments
- July 2024: Coloplast unveiled Heylo, the first digital leakage notification system for stoma users, integrating embedded sensors and a mobile application to alert wearers before breakthrough leakage events.
- May 2024: Coloplast broadened its ostomy portfolio by launching Heylo, SenSura Mio Black, and SenSura Mio Convex Soft with Flex coupling to enhance fit choice and consumer aesthetics.
Global Ileostomy Market Report Scope
As per the scope of the report, ileostomy is a stoma built by bringing the end or loop of small intestine out onto the surface of the skin, or the surgical procedure which creates this opening. Intestinal waste passes out of the ileostomy and is collected in an artificial external pouching system which is adhered to the skin This report is segmented by Procedure Type, by Equipment Type, by Disease Type, and by Geography.
By Procedure Type | End Ileostomy | ||
Loop Ileostomy | |||
By Equipment Type | Stoma Bags | ||
Belts & Girdles | |||
Accessories & Others | |||
By Disease Type | Cancer | ||
Crohn’s Disease | |||
Ulcerative Colitis | |||
Other Indications | |||
By System Type | One-Piece Systems | ||
Two-Piece Systems | |||
By Usability | Drainable Bags | ||
Closed-End Bags | |||
By End User | Hospitals | ||
Home-care Settings | |||
Ambulatory Surgical Centers | |||
By Geography | North America | United States | |
Canada | |||
Mexico | |||
Europe | Germany | ||
United Kingdom | |||
France | |||
Italy | |||
Spain | |||
Rest of Europe | |||
Asia-Pacific | China | ||
Japan | |||
India | |||
Australia | |||
South Korea | |||
Rest of Asia-Pacific | |||
Middle East & Africa | GCC | ||
South Africa | |||
Rest of Middle East & Africa | |||
South America | Brazil | ||
Argentina | |||
Rest of South America |
End Ileostomy |
Loop Ileostomy |
Stoma Bags |
Belts & Girdles |
Accessories & Others |
Cancer |
Crohn’s Disease |
Ulcerative Colitis |
Other Indications |
One-Piece Systems |
Two-Piece Systems |
Drainable Bags |
Closed-End Bags |
Hospitals |
Home-care Settings |
Ambulatory Surgical Centers |
North America | United States |
Canada | |
Mexico | |
Europe | Germany |
United Kingdom | |
France | |
Italy | |
Spain | |
Rest of Europe | |
Asia-Pacific | China |
Japan | |
India | |
Australia | |
South Korea | |
Rest of Asia-Pacific | |
Middle East & Africa | GCC |
South Africa | |
Rest of Middle East & Africa | |
South America | Brazil |
Argentina | |
Rest of South America |
Key Questions Answered in the Report
What is the current Ileostomy Market size?
The Ileostomy Market is projected to register a CAGR of 7.3% during the forecast period (2025-2030)
Who are the key players in Ileostomy Market?
ConvaTec Inc., B. Braun Melsungen AG, Coloplast, Hollister Incorporated and Salts Healthcare are the major companies operating in the Ileostomy Market.
Which is the fastest growing region in Ileostomy Market?
Asia-Pacific is projected to register the quickest 8.84% CAGR, driven by expanding hospital capacity and population ageing
Which region has the biggest share in Ileostomy Market?
In 2025, the North America accounts for the largest market share in Ileostomy Market.
What are the main restraints on market growth?
Minimally invasive bowel-sparing surgeries reduce ostomy creation in developed countries, and reimbursement gaps in developing economies limit premium product uptake.